Shared reading may be a helpful therapy, and an alternative to CBT, to help those living with chronic pain, a new study reports.
A new study shows sufferers of seasonally affective disorder (SAD), like insomniacs, report sleep patterns incorrectly due to depression.
Researchers are testing a new method that could help find the best anti-depressants for individual patients more efficiently.
Researchers report a reduction in neuroticism for people with generalized anxiety disorder who successfully completed metacognitive therapy or cognitive behavioral therapy.
Researchers propose a variety of therapeutic approaches and medications to help combat adult nightmare disorder.
Study reports people with insect phobias reported a 20% reduction in symptoms following seven-seconds of exposure to the superhero movies Spiderman and Antman.
From comfort eating to hormonal levels contributing to a desire for sweets, many studies have investigated why women with PMS often crave certain foods. Researchers explore why food cravings may occur, and what can be done to suppress them for women with premenstrual syndrome.
Effective neurochemical changes in the brain of those with social anxiety take different forms after SSRI treatment and cognitive behavioral therapy.
Neuroimaging predicts whether a person with OCD will respond to stress-reduction therapy or exposure-based therapy best. Analyzing brain activity may help to provide tailored treatments to individuals suffering from OCD.
Moment-to-moment fluctuations in brain activity over a three-minute period can reliably predict how receptive a person with social anxiety will be to cognitive behavioral therapy.
A new study reports people with depression or anxiety can benefit from online cognitive behavioral therapy.
Only 45% of patients with major depressive disorder find benefit from cognitive behavioral therapy (CBT). A neuroimaging study reveals those who respond to CBT have greater neural activity in the right striatum and right amygdala pretreatment than those who find little benefit from the treatment. The findings could serve as a biomarker to discover who will respond to CBT.
